Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 31 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

23%

7 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

11 recruiting

Enrollment Performance

Analytics

Phase 4
6(42.9%)
N/A
3(21.4%)
Phase 1
3(21.4%)
Phase 2
1(7.1%)
Phase 3
1(7.1%)
14Total
Phase 4(6)
N/A(3)
Phase 1(3)
Phase 2(1)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (31)

Showing 20 of 31 trials
NCT07543263Not Yet Recruiting

An Artificial Intelligence System for Multimodal, Multi-class Diagnosis of Pancreatic Cystic Lesions Based on Endoscopic Ultrasonography

Role: collaborator

NCT07536932Not Yet Recruiting

Triage and Recognition of Acute Aortic Dissection in Chest Pain by Electrocardiogram-Artificial Intelligence

Role: collaborator

NCT06538883Not ApplicableRecruiting

Sedation in ICU Patients With Mechanical Ventilation

Role: collaborator

NCT07495111Not ApplicableRecruiting

Prophylactic PS Placement to Prevent Pancreatitis After Endoscopic Transpapillary GPC for Cholelithiasis With Concomitant Choledocholithiasis

Role: collaborator

NCT07413068Recruiting

Treatment Outcomes and Complications of Three Therapeutic Approaches for Concomitant Choledocholithiasis and Cholecystolithiasis

Role: collaborator

NCT07381192Recruiting

An Artificial Intelligence System for Multimodal, Multi-class Diagnosing Solid Pancreatic Lesions Based on Endoscopic Ultrasound

Role: collaborator

NCT07379255Recruiting

Evaluation of Postoperative Adjuvant Chemotherapy Efficacy for Bladder Cancer Based on Organoid Technology.

Role: collaborator

NCT07379281Recruiting

Evaluating the Efficacy of Neoadjuvant Chemotherapy Drugs Based on Organoid Technology

Role: collaborator

NCT07379268Recruiting

Evaluation of the Efficacy of Anti-HER2 Antibody-Drug Conjugates (ADC) in Locally Advanced or Metastatic Bladder Cancer Based on Organoid Technology.

Role: collaborator

NCT06541106Recruiting

Registry of Endovascular Treatment for Vertebrobasilar Dissecting Aneurysms in China

Role: collaborator

NCT03649503Recruiting

The National Registry Study For the Real-world Patients With Parkinsonian Disorders in China

Role: collaborator

NCT07152886Phase 4Not Yet Recruiting

The Effects of Clostridium Butyricum on Adverse Events During Adjuvant Chemotherapy for Colorectal Cancer

Role: collaborator

NCT06718725Recruiting

An Artificial Intelligence System for ROSE of EUS-FNA Sample: a Prospective, Multicenter, Diagnostic Study.

Role: collaborator

NCT06662071Recruiting

A Research Protocol for Evaluating the Efficacy of Perfused Chemotherapeutic Agents for Bladder Cancer Based on Organoid Technology

Role: collaborator

NCT06285136Phase 2Not Yet Recruiting

Safety and Efficacy of Venetoclax Combination With Decitabine(DEC3-VEN) in the Treatment of AML in the Adult

Role: collaborator

NCT06186947Unknown

Effects of COVID-19 Infection on Pregnancy Outcomes and Offspring Health

Role: collaborator

NCT05981079Phase 4Unknown

Model-based Dose Versus Empirical Dose of Piperacillin/Tazobactam in Preterm Neonates With Late-onset Sepsis.

Role: collaborator

NCT05949762Phase 1Unknown

Safety and Efficacy of Venetoclax in Combination With Azacitidine and HA Regimen in the Treatment of AML in the Elderly

Role: collaborator

NCT05893472Phase 1Unknown

A Study on the Efficacy and Safety of Venetoclax Combined With HAA Regimen in Newly Diagnosed Young AML.

Role: collaborator

NCT05173493Completed

The Study About the Selection of Time for Retreatment of Helicobacter Pylori After Eradication Failure

Role: collaborator